Morning Trend | HENGRUI PHARMA (1276.HK) faces pressure with reduced volume, is the sector rotation about to change?

HENGRUI PHARMA (1276.HK) showed significant sensitivity in capital flow after the market closed yesterday, with overall trading volume remaining sluggish throughout the day and a lack of obvious buying pressure returning to the stock. The stock continued to oscillate weakly below the short-term moving averages. The main funds maintained a wait-and-see trend, with short-term trading activity noticeably declining, and large funds primarily adopting a defensive posture. Recently, the A-share pharmaceutical sector has been under overall pressure, influenced by policy signals such as "drug price negotiations" and "adjustments to the medical insurance catalog." As an industry leader, market expectations for HENGRUI have continued to be suppressed. Institutional investors are hesitant to bottom-fish, and retail investors are also showing obvious caution and waiting on the sidelines, further amplifying the atmosphere of caution in the market. From a technical perspective, the daily MACD has just formed a death cross, and the moving averages are in a bearish arrangement, putting overall pressure on the market. Intraday, right-side traders are more inclined to control their exposure, resulting in a generally cautious atmosphere. From the market's viewpoint, if there are positive changes in policies or at the industry or company level, there may still be a window for recovery in the sector. However, at this stage, it is crucial to focus on previous lows and related policy dynamics. If key support is breached, there is a risk of further inertia downward in the stock price. In the short term, close attention should be paid to intraday volume, industry policies, and sector rotation signals to guard against sudden risks